Correlation Between Epigenomics and Bristol-Myers Squibb
Can any of the company-specific risk be diversified away by investing in both Epigenomics and Bristol-Myers Squibb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Epigenomics and Bristol-Myers Squibb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Epigenomics AG and Bristol Myers Squibb, you can compare the effects of market volatilities on Epigenomics and Bristol-Myers Squibb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Epigenomics with a short position of Bristol-Myers Squibb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Epigenomics and Bristol-Myers Squibb.
Diversification Opportunities for Epigenomics and Bristol-Myers Squibb
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Epigenomics and Bristol-Myers is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Epigenomics AG and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Epigenomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Epigenomics AG are associated (or correlated) with Bristol-Myers Squibb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Epigenomics i.e., Epigenomics and Bristol-Myers Squibb go up and down completely randomly.
Pair Corralation between Epigenomics and Bristol-Myers Squibb
If you would invest 50.00 in Epigenomics AG on January 26, 2024 and sell it today you would earn a total of 0.00 from holding Epigenomics AG or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Epigenomics AG vs. Bristol Myers Squibb
Performance |
| Timeline |
| Epigenomics AG |
| Bristol Myers Squibb |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Epigenomics and Bristol-Myers Squibb Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Epigenomics and Bristol-Myers Squibb
The main advantage of trading using opposite Epigenomics and Bristol-Myers Squibb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Epigenomics position performs unexpectedly, Bristol-Myers Squibb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will offset losses from the drop in Bristol-Myers Squibb's long position.| Epigenomics vs. BiodesixInc | Epigenomics vs. Aclaris Therapeutics | Epigenomics vs. Castle Biosciences | Epigenomics vs. Prenetics Global |
| Bristol-Myers Squibb vs. Novartis AG | Bristol-Myers Squibb vs. Bayer Aktiengesellschaft | Bristol-Myers Squibb vs. Astellas Pharma | Bristol-Myers Squibb vs. Roche Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |